HEPATITIS A VIRUS ANTIBODY IGM (HAV IGM) ANTIBODY

The HEPATITIS A VIRUS ANTIBODY IGM (HAV IgM) test detects IgM-class antibodies produced by the immune system in response to a recent Hepatitis A virus infection. It is a serological blood test (typically performed by ELISA or chemiluminescence) that indicates acute or very recent infection rather than past exposure or immunity.

This test is used to confirm suspected acute hepatitis A in patients with jaundice, flu‑like symptoms or elevated liver enzymes, and it is valuable for outbreak investigations, contact tracing and public‑health reporting. At-home venous blood collection performed by trained phlebotomists with reporting from UAE‑licensed laboratories provides timely, reliable results and guidance for clinical follow‑up and infection control.

• Anti‑HAV IgM (Hepatitis A IgM antibody)
• Test method: Serology (ELISA / Chemiluminescence)
• Specimen: Serum / Plasma (venous blood)

• Onset of jaundice or dark urine with fatigue and abdominal discomfort
• Elevated liver enzymes (ALT/AST) of unknown cause
• Recent travel to areas with Hepatitis A outbreaks or poor sanitation
• Known exposure to a confirmed Hepatitis A case or contaminated food/water
• During public‑health investigations or workplace/school outbreak screening

• Accurate identification of acute Hepatitis A infection
• Convenient at‑home sample collection by trained professionals
• Rapid reporting from UAE‑licensed laboratories for clinical action
• Supports timely treatment decisions and public‑health containment
• Reduces unnecessary further testing by distinguishing recent from past infection

• At‑home venous blood collection by a certified phlebotomist
• No fasting required; normal medications can usually be continued
• Inform the collector of recent HAV vaccination or immunoglobulin therapy